Literature DB >> 11200574

Trypanosoma cruzi infection of squirrel monkeys: comparison of blood smear examination, commercial enzyme-linked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries.

M Ndao1, N Kelly, D Normandin, J D Maclean, A Whiteman, E Kokoskin, I Arevalo, B J Ward.   

Abstract

BACKGROUND AND
PURPOSE: Wild-caught New World monkeys (NWM) from Central or South America are often infected with Trypanosoma species, including T. cruzi. In humans, T. cruzi causes Chagas' disease. Even in closed monkey colonies, T. cruzi can be propagated by blood-to-blood exposure, sexual activity, and transplacental transmission. Animal handlers and laboratory staff who deal with blood and tissues from infected NWM are at riskfor acquiring Chagas' disease via accidental exposure.
METHODS: We screened 162 blood samples from wild-caught Saimiri sp. monkeys for Trypanosoma species infections by use of blood smear examination, ELISA, and polymerase chain reaction (PCR) analysis. Blood samples from 19 employees with recent history of monkey-associated injuries also were tested.
RESULTS: Six percent (10/162) of the monkey samples were T. cruzi positive on the basis of blood smear examination results, 10.4% (17/162) were positive by ELISA results, and 26.5% (43/162) were positive by PCR results. Other organisms identified by PCR analysis included T. rangeli in two animals, Plasmodium spp. in two animals (P. malariae confirmed by PCR results) and microfilariae in one animal (morphologically, Mansonella perstans). Evidence of trypanosome infection was not found in the 19 employee samples on the basis of results of any of the three aforementioned tests.
CONCLUSIONS: Close attention must be paid to worker safety where wild-caught NWM are used. The PCR analysis has a clear advantage over conventional techniques (ELISA, blood smear) for screening NWM for trypanosome infections during quarantine and after employee injury.

Entities:  

Mesh:

Year:  2000        PMID: 11200574

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  12 in total

1.  Trypanosoma cruzi in non-human primates with a history of stillbirths: a retrospective study (Papio hamadryas spp.) and case report (Macaca fascicularis).

Authors:  Jessica L Grieves; Gene B Hubbard; Jeff T Williams; John L Vandeberg; Edward J Dick; Juan C López-Alvarenga; Natalia E Schlabritz-Loutsevitch
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

2.  Molecular Epidemiology of Trypanosomatids and Trypanosoma cruzi in Primates from Peru.

Authors:  Esar Aysanoa; Pedro Mayor; A Patricia Mendoza; Carlos M Zariquiey; E Angelo Morales; Jocelyn G Pérez; Mark Bowler; Julio A Ventocilla; Carlos González; G Christian Baldeviano; Andrés G Lescano
Journal:  Ecohealth       Date:  2017-11-02       Impact factor: 3.184

3.  Clinical Trypanosoma cruzi Disease after Cardiac Transplantation in a Cynomolgus Macaque (Macaca fascicularis).

Authors:  Elana R Rybak; Steve Shipley; Ivan Tatarov; Tianshu Zhang; Wenji Sun; Gheorghe Braileanu; Lars Burdorf; Evelyn Sievert; Agnes M Azimzadeh; Louis J DeTolla; Richard N Pierson
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

4.  Reversible cysteine protease inhibitors show promise for a Chagas disease cure.

Authors:  Momar Ndao; Christian Beaulieu; W Cameron Black; Elise Isabel; Fabio Vasquez-Camargo; Milli Nath-Chowdhury; Frédéric Massé; Christophe Mellon; Nathalie Methot; Deborah A Nicoll-Griffith
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

5.  A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada.

Authors:  Margaret A Fearon; Vito Scalia; Mary Huang; Irene Dines; Momar Ndao; Philippe Lagacé-Wiens
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

6.  Transmission of Chagas disease via blood transfusions in 2 immunosuppressed pigtailed macaques (Macaca nemestrina).

Authors:  Derek L Fong; Annie E Torrence; Keith W Vogel; Diane E Stockinger; Veronica Nelson; Robert D Murnane; Audrey Baldessari; LaRene Kuller; Michael Agy; Hans-Peter Kiem; Charlotte E Hotchkiss
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

Review 7.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

8.  Surveillance of vector-borne pathogens under imperfect detection: lessons from Chagas disease risk (mis)measurement.

Authors:  Thaís Tâmara Castro Minuzzi-Souza; Nadjar Nitz; César Augusto Cuba Cuba; Luciana Hagström; Mariana Machado Hecht; Camila Santana; Marcelle Ribeiro; Tamires Emanuele Vital; Marcelo Santalucia; Monique Knox; Marcos Takashi Obara; Fernando Abad-Franch; Rodrigo Gurgel-Gonçalves
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

9.  Diagnosis of parasitic diseases: old and new approaches.

Authors:  Momar Ndao
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-12-30

10.  Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment.

Authors:  Yves Jackson; Eric Chatelain; Anne Mauris; Marylise Holst; Qianqian Miao; Francois Chappuis; Momar Ndao
Journal:  BMC Infect Dis       Date:  2013-02-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.